The stock of Emcure Pharma was listed at Rs 1,325.05, a premium of 31.4% to the issue price on the National Stock Exchange.
The company raised a total of Rs 1,952.03 crore through a combination of fresh issue as well as an offer for sale. Emcure Pharma collected Rs 800 crore by selling 7.9 million shares. In comparison, the promoters and other selling shareholders sold 11.4 million shares for a sum of Rs 1,152.03 crore.
IPO Details
Emcure Pharma opened the bidding for subscription on July 03 and ended it on July 05. It set the price band between Rs 960 to Rs 1008 per equity share. The company finalised the allotment of shares on July 08.
Minimum Investment Required
A retail buyer had to apply for a minimum of 14 shares in a single lot for a sum of Rs 14,112. However, the lot size for small and big non-institutional investors was different.
Employee Reservation
The company kept aside up to 108,900 shares for employees which were offered to them at a discount of Rs 90 to the issue price.
BRLMs and Registrar
Kotak Mahindra Capital Company, Axis Capital, J.P. Morgan India, and Jefferies India were the book-running lead managers. Link Intime India handled the work of the registrar for the issue.